Thyroid function in premature infants. The hypothyroxinemia of prematurity

D A Fisher1

  • 1Harbor-UCLA Medical Center, Torrance, USA.

Clinics in Perinatology
|January 19, 1999
PubMed

Insights

Advances in neonatal care have increased survival for premature infants, especially very low birth weight (VLBW) infants. Their immature hypothalamic-pituitary-thyroid (HPT) axis requires specialized testing and management strategies for thyroid disorders.

Area of Science:

  • Neonatal medicine
  • Endocrinology
  • Perinatal health

Background:

  • Perinatal medicine advances reduce premature infant mortality.
  • Increasing survival of very low birth weight (VLBW) infants (28-32 weeks gestation).
  • Immature hypothalamic-pituitary-thyroid (HPT) axis is common in premature infants, especially VLBW cohort.

Purpose of the Study:

  • To develop a nosology for HPT system disorders in premature infants.
  • To facilitate thyroid function testing and interpretation in this population.
  • To guide patient management for thyroid dysfunction in VLBW infants.

Main Methods:

  • Review and synthesis of accumulated information on HPT function in premature infants.
  • Development of a classification system (nosology) for HPT disorders.
  • Establishment of guidelines for thyroid function testing and interpretation.

Main Results:

  • Identification of unique HPT system disorders prevalent in premature infants.
  • Establishment of age- and condition-specific reference ranges for thyroid function tests.
  • Development of a framework for managing thyroid dysfunction in VLBW infants.

Conclusions:

  • A specialized nosology is crucial for understanding and managing HPT disorders in premature infants.
  • Standardized thyroid function testing and interpretation are essential for optimal outcomes.
  • Effective management strategies improve the health of surviving VLBW infants with HPT axis dysmaturation.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...